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Abstract.  In the low density lipoprotein (LDL) recep- 
tor system, blocks in intracellular movement of a  cell 
surface receptor result from naturally occurring muta- 
tions. These mutations occur in patients with familial 
hypercholesterolemia. One class of mutant LDL recep- 
tor genes (class 2 mutations) produces a  receptor 
that is synthesized and glycosylated in the endoplas- 
mic reticulum (ER) but does not reach the cell sur- 
face. These receptors contain serine/threonine-linked 
(O-linked) carbohydrate chains with core N-acetyl- 
galactosamine residues and asparagine-linked (N-linked) 
carbohydrate chains of the high mannose type that are 
only partially trimmed. To determine the site of block- 
age in transport,  we used electron microscope im- 
munohistochemistry to compare the intracellular loca- 
tion of LDL receptors  in normal human fibroblasts 
with their location in class 2  mutant fibroblasts. In 
normal cells, LDL receptors  were located in coated 
pits, coated vesicles, endosomes, multivesicular 
bodies, and portions of the Golgi complex, In contrast, 
the mutant receptors in class 2  cells were almost en- 
tirely confined to rough ER and irregular extensions of 
the rough ER.  Metabolic labeling studies with [3H]glu- 
cosamine confirmed that these mutant receptors con- 
tain core O-linked sugars,  suggesting that the enzymes 
that attach these residues are located in the rough ER 
or the transitional zone of the ER.  These studies 
establish that naturally occurring mutations in cell 
surface receptors can cause the receptors to remain 
trapped in the ER, thereby preventing their normal 
function and producing a  genetic disease. 
ECENT studies in a variety of systems have disclosed 
that animal cells have a mechanism by which they can 
prevent  the  movement to  the  cell  surface  of im- 
properly folded secretory or membrane proteins. The failure 
of such transport has been observed with mutant viral lipid 
envelope proteins (Gething et al.,  1986), chimeric fusions 
between secretory and membrane-bound proteins (Rizzolo 
et al., 1985), and with naturally occurring human mutations 
in the genes for ct-l-antitrypsin (Hercz et al.,  1978) and the 
low density lipoprotein (LDL)  ~  receptor (Tolleshaug et al., 
1983; Yamamoto et al.,  1986). 
Biochemical studies suggest that these abnormal proteins 
are  usually  blocked  in  movement from  the  endoplasmic 
reticulum (ER) to the Golgi complex. The site within the ER 
at which this block occurs has been studied in detail at the 
morphologic level in only one case- that of a chimeric pro- 
tein between growth hormone and the influenza hemaggluti- 
I. Abbreviations used in this paper:  ABC, avidin-biotin complex; Con A, 
concanavalin A, DAB, 3,3'-diaminobenzidine tetrahydrochloride; ER, en- 
doplasmic reticulum; FH, familial hypercholesterolemia; GalNAc, N-ace- 
tylgalactosamine;  HRP, horseradish  peroxidase;  LDL,  low density  lipo- 
protein. 
nin (Rizzolo et al.,  1985). In cells that expressed extremely 
high levels of this fusion protein, the protein accumulated in 
an  abnormal  expanded  compartment  of smooth-surfaced 
membranes that was felt to represent a hypertrophied transi- 
tional zone between the ER and the Golgi complex. Whether 
this same organelle represents the site of blockage in the 
movement of naturally occurring  mutant proteins  is  not 
known. 
In the current studies, we have sought to answer this ques- 
tion by examination of cultured fibroblasts from patients with 
mutations in the gene for the LDL receptor. The LDL recep- 
tor is a 160-kD transmembrane glycoprotein that moves con- 
tinually from one organelle to another  (Goldstein et al., 
1985). In the steady state, most of the receptors are located 
in coated pits on the cell surface. These receptors continually 
enter the cell when coated pits invaginate to form coated vesi- 
cles. LDL that is bound to this receptor is delivered to acidic 
endosomes where it dissociates. The unoccupied receptor 
returns to the cell surface where it binds another LDL and 
initiates another round of internalization. After it is depos- 
ited in the endosome, the LDL is transported to the lysosome 
where it is degraded.  During its 20-h life span each LDL 
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al.,  1983). 
Before it can embark upon this recycling pathway, the LDL 
receptor must first travel to the cell surface from its site of 
synthesis in the rough ER. Its progress along this path can 
be followed biochemically by monitoring the apparent mo- 
lecular mass of the receptor on SDS-polyacrylamide gels 
(Tolleshaug et al., 1983). Newly synthesized LDL receptors 
show an apparent molecular mass of 120 kD on SDS-poly- 
acrylamide gels. These receptor precursors contain several 
immature  high  mannose  N-linked  oligosaccharide chains 
and many O-linked N-acetlygalactosamine (GalNAc) resi- 
dues.  The majority of the  O-linked GalNAc  residues  are 
clustered in a serine- and threonine-rich region of 48 amino 
acids just outside the plasma membrane (Cummings et al., 
1983; Davis et al., 1986). Within 30 min after synthesis, the 
receptor is transported from the ER to the Golgi complex 
where the high mannose N-linked oligosaccharide chains are 
converted to a complex form, and where each of the O-linked 
core GalNAc sugars is modified by addition of galactose and 
sialic acid residues. As a result of  these changes, the apparent 
molecular mass of the receptor increases to 160 kD, an in- 
crease that is attributable mainly to anomalous migration on 
SDS  gels  resulting  from  the  elongation  of the  clustered 
O-linked sugar chains (Cummings et al.,  1983; Davis et al., 
1986).  The mature  160-kD  LDL receptor is rapidly trans- 
ported to the cell surface where it immediately clusters in 
coated pits and begins to recycle whether or not LDL is avail- 
able (Goldstein et al.,  1985). 
The molecular signals that regulate the intracellular traffic 
of the LDL receptor are being elucidated through the study 
of naturally occurring human mutant fibroblasts that synthe- 
size receptors that are defective in intracellular movement. 
These mutations occur in individuals with a common genetic 
disease called familial hypercholesterolemia (FH). One class 
of mutant LDL receptor genes (class 2 mutations) produce 
120-kD LDL receptor precursors that cannot be processed 
to the  mature  160-kD  form (Goldstein et al.,  1985).  The 
120-kD precursor never reaches the cell surface, as revealed 
by  its  resistance  to  digestion  with  extracellular proteases 
(Tolleshaug et al., 1983; Cummings et al., 1983). The N-linked 
sugars remain in the endoglycosidase H-sensitive form, sug- 
gesting that the receptors have not been transported to the 
Golgi stacks. In one of these patients, the trapped precursor 
was shown to contain core GalNAc residues attached to ser- 
ine and threonine (Cummings et al., 1983). This latter modi- 
fication is catalyzed by a polypeptide, GalNAc transferase, 
that  is  thought,  on the basis  of cell fractionation studies, 
to be located in the Golgi complex (Hanover et al.,  1982; 
Abeijon and Hirschberg, 1987). This apparent inconsistency 
in the location of the class 2 mutant LDL receptors and the 
enzymes that modify them can only be resolved by ultra- 
structural studies. 
The molecular basis for two of the class 2 mutations have 
been disclosed through molecular cloning (Yamamoto et al., 
1986). One of these occurs in a strain of rabbits designated 
WHHL rabbits and the other occurs in an FH patient desig- 
nated FH 563. In both instances there is a small in-frame de- 
letion that removes several amino acids from a region of the 
receptor that is  rich in disulfide-bonded cysteine residues. 
We have suggested that the failure of transport results from 
improper folding caused by the deletions with consequent 
failure to form normal disulfide bonds. Aberrant folding has 
been implicated as a cause of slow movement from ER to 
Golgi complex in mutants of viral lipid envelope proteins 
(Gething et al.,  1986). 
In the current studies we have used several techniques of 
histochemical visualization to compare the intracellular lo- 
cation of the LDL receptor in normal human fibroblasts with 
that in fibroblasts from three FH individuals with class 2 mu- 
tations. Our results indicate that in normal cells in the steady 
state the LDL receptor is located primarily in coated pits on 
the cell surface and  in endosomes;  very little receptor is 
found in the ER. In the class 2 mutant cells the receptor is 
located exclusively in the ER and in tubular extensions of the 
ER that are believed to correspond to transition elements be- 
tween this organelle and the Golgi complex. 
Materials and Methods 
Reagents 
We  obtained  BSA  (No.  A-7638),  cycloheximide,  3,3'-diaminobenzidine 
tetrahydrochloride (DAB), Hepes, hydrogen peroxide, saponin, Trizma (hy- 
droxymethyl aminomethane) base, and Trizma hydrochloride from Sigma 
Chemical Co.  (St.  Louis,  MO).  Paraformaldehyde,  tetrachloroauric acid 
(No. 50800), and 2,4,6-trinitrophenol were purchased from Fluka (Haup- 
pauge,  NY).  Lysine monohydrochloride and sodium metaperiodate were 
obtained from Fisher Scientific Co.  (Plano, TX); glutaraldehyde, osmium 
tetroxide, propylene oxide,  and Spurr's low viscosity embedding medium 
from Electron Microscopy Sciences (Fort Washington, PA).  Rabbit immu- 
noglobulin Vectastain avidin-biotin complex (ABC) kit (No. PK4001) con- 
raining afffinity-purified  biotinylated goat anti-rabbit IgG, avidin DH  (re- 
agent A), and biotinylated horseradish peroxidase (HRP) H (reagent B) was 
purchased from Vector Laboratories, Inc. (Burlingame, CA). Affinity-puri- 
fied sheep anti-rabbit IgG conjugated to HRP (No. BI-2407) was obtained 
from Bio-Sys (Compiegne, France). A polyclonal antibody directed against 
the human LDL receptor was prepared by immunizing a New Zealand white 
rabbit with purified bovine receptor as described  (Russell et al.,  1984). 
mAbs IgG-C7 and IgG-2001 were prepared as described (Beisiegel et al., 
1982).  We  obtained  [-%]methionine (1,100  Ci/mmol)  and  D-[1,6-3Hlglu - 
cosamine (30-60  Ci/mmol)  from New  England Nuclear  (Boston,  MA); 
o-[6-3H]glucosamine (20-40 Ci/mmol) from Amersham Corp.  (Arlington 
Heights, IL). DME and PBS (No. 310-4190) were from Grand Island Bio- 
logical Co. (Grand Island, NY); and ITS Premix (containing insulin, trans- 
ferrin, and selenium) was from Collaborative Research Inc. (Bedford, MA). 
Human  LDL  (density,  1.019-1.063  g/ml) and lipoprotein-deficient serum 
(density, >1.215 g/ml) were isolated from the plasma of healthy donors by 
ultracentrifugation  (Goldstein et al.,  1983).  LDL  was  radiolabeled  with 
L25I as described (Goldstein et al.,  1983). 
Pronase was purchased from Calbiochem-Behring Corp.  (La Jolla, CA) 
and concanavalin A (Con A)-Sepharose was obtained from Pharmacia P-L 
Biochemicals (Milwaukee, WI). N,N'-Diacetylchitobiose, N,N',N",-triace- 
tylchitobiose, N,N',Ar,N'~-tetraacetylchitotetraose,  and N,N',N",N",N'~-penta  - 
acetylchitopentaose were prepared from chitin (Sigma Chemical Co.) by the 
procedure of Rupley (1964).  The reduced forms of these oligosaccharides 
were prepared by reduction with NaB3H4. N-[3H]Acetylglucosaminitol and 
N-[t4C]acetylgalactosaminitol  were  prepared  by  NaBH4  reduction of the 
appropriate radiolabeled reducing sugars and were purified after reduction 
by passage over a column of mixed bed ion exchange resin in water.  The 
disaccharide  standard  [3H]GaI-131,4GIcNAc  was  prepared  enzymatically 
from  GIcNAc  (Sigma Chemical  Co.)  using bovine galactosyltransferase 
(UDP-galactose/D-glucose-4-galactosyl-transferase,  Sigma Chemical  Co.) 
and UDP-[6-3H]galactose (Amano et al.,  1988).  The reduced form of this 
disaccharide was prepared by reduction with NaBH4.  The standard Gall31,3- 
[3H]GalNAcitol  was  prepared  from  glycoproteins derived  from  [3H]glu - 
cosamine-labeled adult schistosomes (Nyame et al.,  1987). 
Cell Culture 
Human fibroblasts were derived from skin biopsies obtained from normal 
subjects and subjects with FH. Cells were grown in monolayers and set up 
for experiments according to a standard format (Goldstein et al.,  1983).  On 
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taining 3 ml DME supplemented with 100 U/ml penicillin, 100/ag/ml  strep- 
tomycin, and 10% (vol/vol) FCS. Fresh medium of the same composition 
was added on day 3. On day 5 of cell growth, each monolayer received 2 ml 
of medium supplemented with penicillin, streptomycin, 5  ~tg/ml insulin, 
5  ~g/ml transferrin, 5  I.tg/ml selenium, and  10%  (vol/vol) human lipo- 
protein-deficient serum. All experiments except those in Fig. 5 were per- 
formed on day 7 after a 48-h incubation in lipoprotein-deficient serum. The 
experiments in Fig. 5 were performed on day 6 after a 24-h incubation in 
lipoprotein-deficient serum. 
lmmunochemical Analysis of  LDL Receptors 
On day 6 of cell growth, monolayers of fibroblasts were pulse-labeled with 
[35S]methionine  or [3H]glucosamine, and the isotopically labeled LDL re- 
ceptors were immunoprecipitated with antireceptor mAb IgG-C7 and ana- 
lyzed by electrophoresis on 7% SDS-polyacrylamide gels, followed by au- 
toradiography (Tolleshaug et al.,  1983). Apparent molecular masses of the 
radiolabeled proteins were calculated by positions of migration of the fol- 
lowing standards as determined by Coomassie Blue staining: myosin (200 
kD), 13-galactosidase (116 kD), phosphorylase G (97 kD), and BSA (68 kD). 
Analysis of  Radiolabeled Glycopeptides and 
Oligosaccharides Released from LDL Receptors 
The following procedures were performed as described by Cummings et al. 
(1983) and David et al. (1986):  labeling of LDL receptors in intact fibro- 
blasts with [3H]glucosamine, preparation and separation of 3H-labeled gly- 
copeptides, treatment of glycopeptides with mild alkaline borohydride, and 
paper chromatography of 3H-oligosaccharides  released from glycopeptides. 
lmmunocytochemical Localization of  LDL Receptors 
ABC Immunoperoxidase Method. On day 7 of cell growth, fibmblast mono- 
layers were fixed for 1 h at room temperature with a fixative that contained 
3 % (wt/vol) paraformaldehyde and 0.069%  (wt/vol) trinitrophenol in buffer 
A (100 mM Hepes, 4 mM CaCI2, 2 mM KCI, and 4 mM MgCI2 at pH 7.4) 
followed by three washes (2 ml each) with buffer B (50 mM Hepes, 150 mM 
NaCI,  4  mM CaCI2,  2  mM KCI,  and 4  mM MgCI2 at pH 7.4).  Mono- 
layers were then incubated in buffer C  (buffer B containing 0.54%  [wt/ 
roll NH4C1, 0.2%  [wt/vol] BSA, and 0.06%  [vol/vol]  saponin) for 30 rain 
at  room temperature  followed by  three washes with buffer D  (buffer B 
plus 0.2%  BSA and 0.01% saponin). Permeabilized cells were incubated 
with either a nonimmune IgG or a polyclonal anti-LDL receptor IgG (0.1 
mg/ml in buffer D) for 1 h at 37°C.  IgG binding sites were localized using 
the Vectastain  ABC kit with the following modifications: (a) a  1-h incuba- 
tion at 37°C with biotinylated, goat anti-rabbit IgG (diluted 1:222 [vol/vol] 
in buffer D); and (b) a  1-h incubation at 37°C with ABC reagent (1  part 
[vol/vol]  avidin DX  [reagent A] mixed with  1 part [vol/vol]  biotinylated 
HRP [reagent BI in buffer D and preincubated 60 min at room temperature). 
Between each incubation, monolayers were washed three times for 10 min 
each at room temperature with buffer D. After the last wash, dishes were 
rinsed three times, 5 min each, with buffer B and fixed with 2.5% (vol/vol) 
glutaraldehyde and 5 % (wt/vol) sucrose in buffer B overnight at 4°C. Dishes 
were washed three times,  10 min each, with buffer B followed by a brief 
wash with 100 mM Tris-HCl (pH 7.2).  To detect peroxidase activity, ceils 
were incubated with 0.1% (wt/vol) DAB in 100 mM Tris-HCl, pH 6.0, for 
15 min at room temperature. This incubation medium was replaced with 
fresh 0.1%  DAB in 100 mM Tris-HCI (pH 6.0) containing 0.01% (vol/vol) 
H202, and the cells were incubated another 10 min. At the end of the reac- 
tion, dishes were washed six times, 5 min each, with 100 mM Tris-HCl (pH 
7.2) at room temperature. 
Anti-lgG Immunoperoxidase Method. Monolayers subjected to the in- 
dicated treatments were fixed immediately for 45 rain at 4°C in fxative that 
contained 2% paraformaldehyde, 37 mM sodium phosphate buffer,  75 mM 
lysine monohydrochloride, and  10 mM sodium metaperiodate at pH 6.2. 
Cells were then washed with PBS and processed for indirect immunoperoxi- 
dase staining by the method of Louvard et al. (1982) using 0.2 mg/ml of a 
polyclonal anti-LDL receptor antibody and a  1:75 dilution of sheep anti- 
rabbit IgG conjugated to HRP.  Peroxidase reaction product was visualized 
by incubating cells in 0.2%  DAB and 0.01% hydrogen peroxide in 50 mM 
Tris-HCI (pH 6.5) for 10 min at room temperature. Cells were then washed 
and processed for electron microscopy as described (Anderson et al., 1981). 
Preparation of PZlILDL-Gold 
Colloidal gold particles were prepared by the reduction of tetrachloroauric 
acid with trisodium citrate (Frens, 1973). [~25I]LDL (1.7 x  106 cpm/ng pro- 
tein; 5 mg/ml) was dialyzed against 50 mM sodium EDTA at pH 6 at 4°C 
for 2 h. The dialyzed [z25I]LDL was conjugated with colloidal gold at pH 
6, according to the method of Horisberger (1979), by mixing 5 ml of colloi- 
dal gold with 42 ~1 of [1251]LDL (1 mg/ml) and incubating the mixture for 
30  min at  room temperature.  To  remove [~25I]LDL-gold  from unbound 
LDL,  the mixture  was  centrifuged at  17,400 g  in  polyethelene glycol- 
20-coated polysulfone tubes (Oak Ridge type) for 30 min at 4°C. The super- 
natant fraction was discarded, and the loose pellet was carefully collected 
in 0.5 ml of PBS and dialyzed 1 h at 4°C against PBS. The protein concen- 
tration of [125I]LDL in the [125I]LDL-gold preparation was determined by 
scintillation counting in a gamma counter. 
Electron Microscopy 
Cells were postfixed with 2% (wt/vol) OsO4 in 100 mM sodium cacodylate 
(pH 7.2) containing 4.5% sucrose for 90 rain at room temperature. Dishes 
were washed several times with distilled water and incubated with 0.05% 
(wt/vol) uranyl acetate for 10 rain at room temperature. Cells were then de- 
hydrated through graded ethanol and were separated from the dishes using 
propylene oxide (Anderson et al., 1981). After three rinses with propylene 
oxide, the cells were infiltrated with and embedded in Spurr's low viscosity 
embedding medium at 75°C for 18 h. Sections were cut on an ultramicro- 
tome (MT2 B, Sorvall Instruments Div., Newton, CT) and examined with 
an electron microscope (100 CX, JEOL USA, Peabody, MA) without any 
further staining. 
Results 
Distribution of  lntracellular LDL Receptors 
in Normal Fibroblasts 
The total number of LDL receptors in normal human fibro- 
blasts under maximal induction is <70,000 per cell (Gold- 
stein et al., 1983). In mutant fibroblasts the number of recep- 
tors is  much lower.  This low level of expression is at the 
limits  of detection by  electron microscope immunohisto- 
chemistry. To localize this  small number of receptors, we 
used  a  complex amplification technique (the ABC proce- 
dure) in  which fixed cells are permeabilized with saponin 
and then incubated with a rabbit anti-receptor IgG, followed 
by a biotinylated goat anti-rabbit IgG, and then a mixture of 
avidin and biotinylated HRP.  Because of the light fixation 
that is initially used and the many washes that are necessary, 
some of the cytoplasmic detail is not preserved in the micro- 
graphs. Moreover, in order to clearly demonstrate the perox- 
idase reaction product, the photographs must be printed with 
maximal contrast,  which also tends to make the unstained 
areas seem washed out in appearance. The only alternative 
procedure would involve the use of antibody-gold complexes 
on thin sections of cells, which is a less sensitive technique 
than  immunoperoxidase.  Unfortunately, we have been un- 
able to visualize a low number of LDL receptors with the 
gold technique. Although the ABC procedure sacrifices cel- 
lular detail, the visualization was sufficient to allow definite 
conclusions to be drawn, as illustrated below. 
To analyze the  distribution  of the  class  2  mutant  LDL 
receptors, we first had to study the steady-state distribution 
of intracellular receptors in normal cells. Although the sur- 
face distribution of these receptors has been studied exten- 
sively (Anderson et al., 1977, 1982), the distribution ofintra- 
cellular LDL receptors has not been visualized previously by 
electron microscopy. Normal human fibroblasts incubated in 
the absence of LDL were fixed, permeabilized with saponin, 
Pathak et al. lntracellular Localization of Mutant LDL Receptors  1833 Figure 1. Distribution of anti-LDL receptor IgG binding sites in normal human fibroblasts. Monolayers of normal human fibroblasts were 
fixed and processed to localize intracellular LDL receptors using the ABC immunoperoxidase procedure. (A) A low power electron micro- 
graph showing the distribution of anti-LDL receptor IgG binding sites as detected by the presence of electron dense HRP reaction product. 
Arrowheads, coated pit; E, endosomes; uMVB, lightly labeled multivesicular body; eMVB, labeled multivesicular body; RER, rough ER; 
V, small vesicles. (B) Low power electron micrograph showing the distribution of anti-LDL receptor IgG binding sites. Arrowhead, coated 
pit; arrows, Golgi vesicles and cisternae; E, endosomes; cv, coated vesicle; MVB, multivesicular body; N, nucleus. Bar, 0.4 lam. 
and processed for immunoperoxidase localization of LDL 
receptors by the ABC method using a polyclonal anti-LDL 
receptor IgG. Dark HRP reaction product due to anti-LDL 
receptor IgG binding was present in coated pits (arrowhead, 
Fig.  1, A and B), coated vesicles (cv, Fig.  1 B), endosomes 
(E, Fig. 1, A and B), small vesicles (v, Fig. 1 A), multivesicu- 
lar bodies (e MVB and MVB, Fig.  1, A and B, respectively), 
and vesicles and cisternae of the Golgi complex (arrows, Fig. 
1 B).  Reaction product was  not evident in  the  rough ER 
(RER, Fig. 1 A) or the nuclear envelope (Fig. 1 B), and some 
The Journal of Cell Biology, Volume  106, 1988  1834 Figure 2. Distribution of anti-LDL receptor IgG binding sites in mutant human fibroblasts that do not synthesize LDL receptors (class 
l mutation). Monolayers of fibroblasts from FH 549 were fixed and processed to localize LDL receptors by the ABC procedure. Arrowhead, 
coated pit; RER, rough ER; G, Golgi complex; SER, irregular extensions of the RER. Bar, 0.4 I.tm. 
multivesicular  bodies  had  a  reduced  amount  of reaction 
product (uMVB, Fig.  1 A). As a control for the specificity 
of the antibodies used in these experiments, we studied mu- 
tant fibroblasts that do not synthesize any immunoreactive 
LDL receptors (class 1 mutation). No HRP reaction product 
was detected in any intracellular compartment of these cells 
(Fig. 2). Moreover, when normal fibroblasts were processed 
using a nonimmune primary antibody, HRP reaction product 
was not detected (data not shown). 
The receptor-positive membranes in the endocytic path- 
way were further defined by localizing receptors in cells that 
had been incubated with LDL-gold to mark the sites of LDL 
internalization and accumulation (Fig.  3, A and B).  LDL- 
gold particles and  immunodetectabte LDL receptors were 
colocalized in coated pits (arrowhead, Fig.  3  A),  nascent 
coated vesicles (arrowhead, Fig.  3 B), uncoated endocytic 
vesicles (E, Fig. 3, A and B), and some multivesicular bodies 
(MVB,  Fig.  3  A).  Other  multivesicular  bodies  contained 
LDL-gold but little HRP reaction product (MVB, Fig. 3 C). 
Surrounding the multivesicular bodies were numerous small 
vesicles that did not contain LDL-gold but were heavily la- 
beled with HRP reaction product (arrows, Fig. 3, C and D). 
Some of  these receptor-positive vesicles appeared to be in the 
process of budding from the multivesicular body membrane 
as evidenced by their location at the ends of membranous 
stalks (arrowhead, Fig.  3,  C and D). 
LDL Receptors in Golgi Complex Are 
Newly Synthesized 
The receptors that were seen in the Golgi complex (Fig.  1 
B) could represent receptors that are recycling through this 
compartment en route to the cell surface or they could repre- 
sent  newly  synthesized receptors.  To distinguish  between 
these possibilities, we incubated fibroblasts in the presence 
of  cycloheximide for 4 h to prevent receptor synthesis (Brown 
et al.,  1981). This treatment does not affect the internaliza- 
tion or recycling of already synthesized receptors (Brown et 
al.,  1981), hut it should deplete newly synthesized receptors 
from the secretory pathway.  The cycloheximide-treated  cells 
showed a marked depletion of receptors in the Golgi complex 
(Fig. 4, compare B with A). This treatment did not affect the 
distribution of receptors in coated pits (arrowheads, Fig. 4, 
A and B), coated vesicles, or endocytic vesicles. We there- 
fore conclude that the receptors in the Golgi complex were 
newly synthesized, rather than recycling, receptors. Consis- 
tent with this interpretation was our failure to observe inter- 
nalized LDL-gold in any portion of the Golgi complex (data 
not shown). 
Biochemical Analysis of  120-kD Receptor 
in Fibroblasts with Class 2 Mutation 
Fibroblasts from three unrelated FH homozygotes with class 
2 mutations were studied. The defect in LDL receptor pro- 
cessing was demonstrated by incubating the cells in the pres- 
ence of pS]methionine  for 60  min and  then transferring 
them to medium that contained an excess of unlabeled methi- 
onine for 2  h.  The LDL receptor was immunoprecipitated 
from detergent-solubilized cells and analyzed by SDS-PAGE 
and autoradiography (Fig. 5). After a 60-rain pulse, the nor- 
mal cells showed about equal amounts of the 120-kD precur- 
sor and  160-kD  mature receptor (Fig. 5, lane 2). After 2 h 
of chase, virtually all of the precursor was converted to the 
mature form (lane 3). In cells from two of the class 2 mu- 
tants, FH 429 and FH 261, no detectable amount of  precursor 
was converted to the mature form (lanes 6 and 9). In cells 
from one class 2 mutant, FH 563, a small amount of precur- 
sor ('~5 % by densitometry of the gels) was processed to the 
mature form (lane 12). These results are similar to previous 
results with the class 2 mutant cells (Tolleshaug et al.,  1983; 
Yamamoto et al.,  1986). 
The glycosylation of the 120-kD receptor precursors from 
normal fibroblasts and fibroblasts from two of the class 2 mu- 
Pathak et al. lntracellular  Localization  of Mutant LDL Receptors  1835 Figure 3. Colocalization of LDL-gold and anti-LDL receptor IgG binding sites in normal human fibroblasts. Monolayers of normal human 
fibroblasts were incubated for 30 rain at 37°C with 20 I.tg protein/ml of LDL-gold. At the end of the incubation, the cells were washed 
with PBS, fixed, and processed for the localization of LDL receptors using the anti-IgG  immunoperoxidase procedure. (A and B) Both 
LDL-gold and anti-LDL receptor lgG binding in coated pit (arrowheads), endosomes (E), and multivesicular bodies (MVB). (C and D) 
Multivesicular bodies (MVB) that contained LDL-gold and anti-LDL receptor IgG binding sites. Arrows, receptor-positive vesicles sur- 
rounding multivesicular bodies; arrowheads, receptor-positive evaginations from multivesicular body membrane. Bar, 0.2 ~tm. 
tants, FH 429 and FH 563, were analyzed by metabolic ra- 
diolabeling (Cummings et al.,  1983).  The cells were incu- 
bated in medium containing [3H]glucosamine, and the LDL 
receptors were immunoprecipitated and subjected to SDS- 
PAGE and fluorography as described in Materials and Meth- 
ods.  [3H]Glucosamine  was  incorporated  into  the  120-kD 
receptor precursor of all three cell strains (data not shown). 
The observation that the LDL receptor precursor in nor- 
mal fibroblasts is glycosylated is consistent with the results 
of our previous study in which the receptor precursor was 
found to contain both O-linked chains and high mannose-type 
Asn-linked sugar chains (Cummings  et al.,  1983).  In that 
study we found that a large amount of [3H]glucosamine-de- 
rived material was contained in O-linked sugar chains that 
did not bind to Con A-Sepharose.  Con A-Sepharose does 
not bind glycopeptides containing O-linked sugar chains. It 
also does not bind certain complex-type tri- and tetraanten- 
nary and bisected biantennary asparagine-linked sugar chains 
(Cummings and Kornfeld,  1984). 
To determine whether the [3H]glucosamine in the mutant 
120-kD receptors was in O-linked sugar chains, the 120-kD 
band was excised from the SDS gel and digested with pro- 
nase. The resulting 3H-labeled glycopeptides were analyzed 
by previously described techniques (Cummings et al.,  1983; 
Davis et al., 1986). The glycopeptides were first fractionated 
by chromatography on Con A-Sepharose (Fig.  6).  Greater 
than 95 %  of the radioactivity from the normal precursor 
(Fig. 6 A) and the FH 563 precursor (Fig. 6 C) and 85% of 
that from FH 429 precursor (Fig. 6 B) did not bind to Con 
A-Sepharose. The remainder of the radioactivity from the 
FH 429 receptor required 100 mM et-methyl-mannoside for 
elution,  a  behavior that  is  typical for high  mannose-type 
asparagine-linked sugar chains (Cummings et al.,  1983). 
The [3H]glucosamine-labeled glycopeptides that did not 
bind to Con A-Sepharose were treated with mild base boro- 
hydride and then analyzed by descending paper chromatog- 
raphy.  This treatment releases O-linked sugars from serine 
and threonine residues in peptides via a I~-elimination  reac- 
The Journal of Cell Biology, Volume  106, 1988  1836 Figure 4. Distribution  of anti-LDL receptor IgG binding sites in the Golgi complex of normal human fibroblasts that were incubated in 
the absence (A) or presence (B) of cycloheximide. Monolayers of normal human fibroblasts were incubated in the absence (A) or presence 
(B) of 200 ~M cycloheximide for 4 h at 37°C. At the end of the incubation,  the cells were fixed and processed for localization of LDL 
receptors using the ABC immunoperoxidase procedure as described. (A) Arrows, Golgi cisternae and vesicles that contain anti-LDL recep- 
tor IgG binding sites; arrowheads, coated pits. (B) Arrows, Golgi cisternae  and vesicles; arrowheads, coated pits. Bar, 0.4 Ixm. 
tion (Carlson,  1968; Baenziger and Kornfeld,  1974). Glyco- 
peptides from the two mutant cell strains yielded two major 
radiolabeled  species  that  had  chromatographic  mobilities 
similar to tri- and tetrasaccharides (Fig. 7, A and B).  These 
results are similar to those obtained previously with the LDL 
receptor precursor from normal  fibroblasts (Cummings et 
al.,  1983) and indicate that the receptor precursors accumu- 
lating in the FH 429 and FH 563 cells contain O-linked sugar 
chains. 
lntracellular Localization of the 120-kD LDL 
Receptor in Fibroblasts with Class 2 Mutation 
The distribution of LDL receptors in the class 2 mutant cells 
was  analyzed by electron  microscopy using  the  ABC  im- 
munoperoxidase procedure. Only faint traces of LDL recep- 
tor reaction product were detectable on the cell surface, in 
coated pits (arrowhead, Fig. 8, A and C), or in recognizable 
vesicles in the endocytic pathway (MVB, Fig. 8 B). Instead, 
most of the reaction product was present in elements of the 
rough ER (RER, Fig. 8, A, C, and D). The highest concentra- 
tion of reaction product was in membrane extensions of the 
rough ER (SER, Fig. 8, A and C) that appeared to be devoid 
of ribosomes.  In addition,  irregularly  shaped vesicles (ar- 
rows, Fig. 8, A and B) that contained reaction product were 
scattered  throughout  the  cell.  Each  of the  three  FH  cell 
strains that we studied-FH 429, FH 261, and FH 563-had 
the  same LDL receptor distribution  (Fig.  8,  A,  B,  and  C, 
respectively) except that FH 563 cells had a somewhat larger 
amount  of HRP  reaction  product  in  coated pits  (data  not 
shown).  This finding is consistent with the small degree of 
receptor processing that occurs in this mutant (Fig.  5). 
The irregularly shaped vesicles that contained LDL recep- 
tors appeared to represent extensions of the rough ER where 
the connection with rough ER was in a different plane of sec- 
tion. To make certain that these vesicles were not part of the 
endocytic pathway, we incubated class 2 mutant cells in the 
presence of colloidal gold to delineate endocytic vesicles that 
participated  in  bulk-phase  uptake  and  then  processed  the 
cells for receptor localization. As seen in Fig. 8 D, the vesi- 
Figure 5. Biosynthesis and processing of LDL recep- 
tors  in  flbroblasts  from  three  different  FH  homo- 
zygotes with the class 2 mutation. On day 6 after incu- 
bation for 24 h in lipoprotein-deficient  serum,  cells 
from the  indicated  subject  were  pulse  labeled  for 
60 min with  110 laCi/ml [35S]methionine in methio- 
nine-free medium and either  not chased (lanes 2, 5, 
8,  and  1/) or chased  for 2 h  in medium  containing 
200 gM unlabeled methionine (lanes 1, 3, 4, 6,  7, 9, 
10, and 12). Detergent-solubilized cell extracts were 
prepared and subjected to immunoprecipitation  with 
either anti-LDL receptor mAb IgG-C7 (Immune) or 
an  irrelevant  mAb IgG-2001 (Nonimmune) as  indi- 
cated.  The  immunoprecipitates  were  processed  for 
SDS-PAGE and  autoradiography.  The  gel  was  ex- 
posed to x-ray film for 18 h. The positions of migra- 
tion of the receptor precursor (120 kD) and the mature 
receptor  (160 kD) are indicated. 
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Figure 6.  Chromatography on Con A-Sepharose of radiolabeled 
glycopeptides  from the  120-kD LDL receptor precursor isolated 
from normal and two different FH homozygotes with the class 2 
mutation. On day 6 after incubation for 24 h in iipoprotein-deficient 
serum, 10 dishes (60 mm) from a normal subject (A) and 35 dishes 
(60 mm) from an FH subject (B, FH 429 mutant;  C, FH 563 mu- 
tant)  were  washed  with  PBS,  preincubated  for  1 h  at  37°C  in 
glucose-free  DME  supplemented  with  10%  lipoprotein-deficient 
serum, and then pulse labeled for either 20 min (A) or 2.5 h (B and 
C)  with  200  I.tCi/ml of [3H]glucosamine.  Detergent-solubilized 
cell extracts were prepared and immunoprecipitated  with anti-LDL 
receptor  mAb.  The  immunoprecipitates  were  subjected  to elec- 
trophoresis  in 7 % SDS-polyacrylamide gels. LDL receptors  were 
located  by fluorography,  excised  from the gel, and digested  with 
Pronase.  The  released  [3H]glycopeptides  from  the  antireceptor 
immunoprecipitates  were chromatograpbed on Con A-Sepharose 
as described in Materials  and Methods.  As denoted by the arrows, 
10 mM a-methyl glucoside (arrow 1 ) or 100 mM I~-methyt manno- 
side (arrow 2) were applied to elute glycopeptides bound by the lec- 
tin. Portions of each fraction were removed and counted for radio- 
activity. Horizontal lines represent  the fractions of the run-through 
material  that were pooled for further analysis  in Fig.  7. 
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Figure 7.  Descending paper chromatograms of [3H]glucosamine- 
labeled oligosaccharides released by NaOH/NaBH4 from the class 
2  mutant  receptors.  The  [~H]glucosamine-labeled  glycopeptides 
from the mutant receptors  (A, FH 429; B, FH 563) were fraction- 
ated on Con A-Sepharose as described in Fig. 6. The glycopeptides 
not bound by the lectin  were treated  with NaOH/NaBH4, and the 
released  radioactivity  was analyzed by descending  paper chroma- 
tography as described in Materials  and Methods.  The migration of 
standards  is indicated  by the arrowheads and corresponds to the 
following:  1,  N,N',N",N",N"'-[3H]pentaacetylchitopentaitol;  2, 
N,N',N",N'[3H]tetraacetylchitotetraitol;  3,  N,N',N"[3H]triacetyi - 
cbitotriitol;  4,  [3H]Gall31,4GlcNacitol;  5,  N,N'[3H]diacetyichi - 
tobiitol;  6,  Call31,3[3H]GalNAcitol;  7,  [3H]GlcNAcitol;  and  & 
[t4C]GalNAcitol. 
cles that contained gold particles did not contain LDL recep- 
tor reaction product (Fig.  8 D, inset). 
We also analyzed the Golgi complex of the class 2 mutant 
cells to determine  if any receptor became localized to this 
compartment.  In all mutant cells examined, there was very 
little receptor in this compartment as compared with normal 
cells  (Fig.  9,  compare A with B). 
Discussion 
The current results establish the following new points about 
the intracellular distribution of the LDL receptor in normal 
human  fibroblasts:  (a)  internalized  LDL receptors  can  be 
visualized,  together with their ligand, in irregularly shaped 
multivesicular bodies that resemble the structures previously 
defined as endosome8 (Helenius et al.,  1983), receptosomes 
(Pastan  and  Willingham,  1981),  or  compartment  of un- 
coupling  of receptor  and  ligand  (Geuze et  al.,  1983);  (b) 
within the multivesicular bodies the LDL receptors appear 
clustered in regions that have the appearance of budding vesi- 
cles,  which may represent  the morphologic counterpart of 
previously  postulated  recycling  vesicles  (Brown  et  al., 
1983); and (c) some receptors were associated with the Golgi 
complex, but these appear to be newly synthesized receptors, 
since they disappear within 4  h after inhibition of receptor 
synthesis with cycloheximide. 
The above pathway for recycling of the LDL receptor in 
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pathways for the asialoglycoprotein receptor, the mannose-6- 
phosphate receptor, and the polymeric IgA receptor in hepa- 
tocytes (Geuze et al.,  1983,  1984), and for the mannose-6- 
phosphate receptor in fibroblasts (Brown et al., 1986). Previ- 
ous studies of the fibroblast endosome have revealed it to be 
a morphologically complex structure consisting of a central 
vacuole with many radiating tubular extensions (Marsh et 
al., 1986). The LDL receptor-rich vesicles that we observed 
in association with multivesicular bodies most likely cor- 
respond to cross-sectional profiles of these tubular exten- 
sions. These data suggest that once the LDL receptor reaches 
the endosome, it migrates into these tubules. These tubules 
give rise to vesicles that carry the receptor back to the cell 
surface. 
In  fibroblasts from FH patients previously identified as 
having the class 2 mutant phenotype at the LDL receptor lo- 
cus, the receptor was found almost exclusively in the rough 
ER and in tubulo-vesicular structures that appeared to be 
smooth-surfaced extensions of the ER, although we cannot 
be sure that the peroxidase reaction product did not obscure 
ribosomes present on this  membrane.  We found no more 
than trace amounts of receptors in the Golgi complex, on the 
cell surface, in coated pits, or in endocytic vesicles (the latter 
defined as those structures that take up colloidal gold par- 
ticles). 
The LDL receptors produced by the class 2 mutant cells 
remain sensitive to endoglycosidase H  (Tolleshaug et al., 
1983), a finding that is consistent with the morphologic evi- 
dence that these receptors never reach the Golgi complex. 
However, these receptors also contain O-linked sugars (Figs. 
6 and 7). The polypeptide, GalNAc transferase, that attaches 
the initial component of O-linked sugars to serine or threo- 
nine residues in rat liver and cultured human choriocarci- 
noma cells has been reported to be located in the Golgi com- 
plex,  as determined by cell fractionation (Hanover et al., 
1982;  Abeijon  and  Hirschberg,  1987).  The current ultra- 
structural data suggest that these core sugars are added to the 
LDL receptor in the ER of  human fibroblasts. We cannot rule 
out the remote possibility that the class 2 mutant receptors 
move transiently to the Golgi complex where they undergo 
O-linked glycosylation, but not removal of mannose resi- 
dues, and then return to the ER so rapidly that their presence 
is undetectable in the Golgi complex in the steady state.  It 
is also possible that there are cell type-specific differences 
in the subcellular localization of these enzymes. 
The composition of the O-linked sugars  on the  normal 
LDL receptor precursor and on the class 2 mutant precursors 
remains to be determined. In the current studies, the carbo- 
hydrates released from the mutant precursors had mobilities 
comparable to tri- and tetrasaccharides on paper chromatog- 
raphy (Fig. 7). Unfortunately, the small amounts of label in- 
corporated made further characterization impossible.  This 
question may be answered in the future by overexpressing 
normal and class 2 mutant receptors after transfection of the 
respective cDNAs into cultured cells. 
In the mutant FH cells the density of HRP reaction product 
appeared to be greatest in the irregular extensions of the ER, 
which suggests that these extensions were the sites at which 
the movement of the receptor out of the ER was blocked. 
This portion of  the ER is morphologically similar to the tran- 
sitional zone of the ER that has been implicated in the trans- 
port of secretory proteins to the Golgi apparatus  (Palade, 
1975). This ER in class 2 mutant fibroblasts has the same 
morphology as in fibroblasts that do not synthesize an LDL 
receptor (compare SER in Fig. 8 A with SER in Fig. 2), in- 
dicating that it was  not hypertrophied in the mutant cells 
producing an abnormal LDL receptor. This observation is in 
contrast to the hypertrophied transitional elements seen in 
cells  that  were producing  high  levels of the  growth  hor- 
mone-influenza hemagglutinin  fusion  protein  (Rizzolo et 
al.,  1985).  This difference was probably related to the fact 
that mutant fibroblasts produce only small amounts of LDL 
receptors, which can apparently accumulate within this re- 
gion of the ER without causing it to expand. 
Considered together, the available data suggest that the ER 
contains some mechanism for distinguishing between native 
and denatured proteins and that only native protein struc- 
tures  can  migrate  to  the  Golgi  complex.  Further  studies 
should reveal the nature of the mechanism that makes this 
distinction. 
The mutations in the LDL receptor that occur in FH are 
the only naturally occurring mutations in a cell surface re- 
ceptor that have been elucidated to date.  It is  likely that 
similar mutations exist in genes for other receptors and that 
these mutations will produce disease by mechanisms similar 
to those identified for the LDL receptor. Unfortunately, cell 
surface receptors are generally present in only trace amounts 
within cells, thus making morphological studies of naturally 
occurring mutant receptors much more difficult than that of 
model experimental systems, such as viral envelope proteins. 
Despite these technical difficulties, with highly sensitive im- 
munocytochemical methods it is possible to localize mutant 
receptors in intracellular organelles, and the current results 
establish that a major site of blockage in the transport of mu- 
tant cell surface receptors lies in the ER. It is likely that other 
mutant receptors will show a similar defect. 
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Figure 8.  Distribution of anti-LDL receptor IgG binding sites in class 2  mutant fibroblasts. Monolayers of fibroblasts from three different 
FH homozygotes with the class 2  mutation-FH  429 (A), FH 261  (B),  FH 563 (C)-were  fixed and processed for the localization of LDL 
receptors using the ABC immunoperoxidase procedure. A  second set of FH 429 cells was incubated for 45 min at 37°C with a  1:40 dilution 
of colloidal gold particles before processing for localization of LDL receptors (D).  (A-C) Arrowheads,  coated pits; RER, rough ER; SER, 
irregular extensions of the rough ER; MVB, multivesicular bodies; arrows, irregularly shaped vesicles that contain anti-LDL receptor IgG 
binding sites; N,  nucleus, (D) Arrows,  endocytic vesicles that contain colloidal  gold but not anti-LDL  receptor IgG binding sites; RER, 
rough ER;  inset,  high magnification of an endocytic vesicle that contains colloidal  gold but not anti-LDL  receptor binding sites.  Bars: 
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